The group’s principal activities include developing and marketing biological products. The products of the group include Adhexil, Evicel, Quixil and Fibrin Patch. The group operates from Israel, the United States, Europe, and Central and Latin America. The revenue of the group for the year 2006 was $63,765 (thousands).
